Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Ouyang, Wei Wei ^a   Su, Sheng Fa ^a   Ma, Zhu ^a   Hu, Yin Xiang ^a   Lu, Bing ^a   Li, Qing Song ^a   Geng, Yi Chao ^a   Li, Hui Qin ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bone Metastases; Chemotherapy; Non small Cell Lung Cancer; Thoracic Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; NAVELBINE; PACLITAXEL; ANTINEOPLASTIC AGENT; VINBLASTINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE OLIGOMETASTASES; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIMARY TUMOR; RADIATION DOSE; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE; ADOLESCENT; ANALOGS AND DERIVATIVES; BONE NEOPLASMS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SECONDARY; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE; VINBLASTINE; YOUNG ADULT;

EID: 84903835685     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-147     Document Type: Article

References (18)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30. 10.3322/caac.21166, 23335087.
2. Scagliotti GV, Parikh P, Von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008, 26:3543-3551. 10.1200/JCO.2007.15.0375, 18506025.
3. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002, 346:92-98. 10.1056/NEJMoa011954, 11784875.
4. Morgensztern D, Waqar S, Subramanian J, Gao F, Govindan R. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005. J Thorac Oncol 2009, 4:1524-1529. 10.1097/JTO.0b013e3181ba3634, 19752759.
5. Li FH, Lu B, Fu HY, Han L, Li QS, Li HQ. Metastasis features of 546 patients with stage IV non-small cell lung cancer at first visit and the significance in radiotherapy. Chin J Radiat Oncol 2012, 2:122-125.
6. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006, 12:6243s-6249s. 10.1158/1078-0432.CCR-06-0931, 17062708.
7. Tsuya A, Kurata T, Tamura K, Fukuoka M. Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer 2007, 57:229-232. 10.1016/j.lungcan.2007.03.013, 17451841.
8. Su SF, Lu B, Zhang B, Hu YX, Ouyang WW, Li HQ, Wang G, Long JH. A prospective study on concurrent chemotherapy and thoracic three-dimensional radiotherapy for stage IV non-small cell lung cancer (1)--survival and toxicity. Chin J Radiat Oncol 2011, 6:467-472.
9. Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-small Cell Lung Cancer and Oligometastasis at Diagnosis. Int J Radiat Oncol Biol Phys 2012, 84:e61-e67. 10.1016/j.ijrobp.2012.02.054, 3919541, 22503522.
10. Arrieta O, Villarreal-Garza C, Zamora J, Blake-Cerda M, de la Mata MD, Zavala DG, Muñiz-Hernández S, de la Garza J. Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation. Radiat Oncol 2011, 6:166. 10.1186/1748-717X-6-166, 3235073, 22118497.
11. Scagliotti GV, De Marinis F, Rinaldi M, Crinò L, Gridelli C, Ricci S, Matano E, Boni C, Marangolo M, Failla G. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 2002, 20:4285-4291. 10.1200/JCO.2002.02.068, 12409326.
12. Higginson DS, Chen RC, Tracton G, Morris DE, Halle J, Rosenman JG, Stefanescu M, Pham E, Socinski MA, Marks LB. The impact of local and regional disease extent on overall survival in patients with advanced stage IIIB/IV non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 2012, 84:e385-e392. 10.1016/j.ijrobp.2012.04.045, 22857887.
13. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995, 13:8-10.
14. Hirano Y, Oda M, Tsunezuka Y, Ishikawa N, Watanabe G. Long-term survival cases of lung cancer presented as solitary bone metastasis. Ann Thorac Cardiovasc Surg 2005, 11:401-404.
15. Azzoli CG, Temin S, Aliff T, Baker S, Brahmer J, Johnson DH, Laskin JL, Masters G, Milton D, Nordquist L. Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. J Clin Oncol 2011, 29:3825-3831. 10.1200/JCO.2010.34.2774, 3675703, 21900105.
16. Reinfuss M, Mucha-Malecka A, Walasek T, Blecharz P, Jakubowicz J, Skotnicki P, Kowalska T. Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity. Lung Cancer 2011, 71:344-349. 10.1016/j.lungcan.2010.06.019, 20674068.
17. Tian J, Shi RH, Jiang T, Zeng ZC, Zhang X, Bai CX. Influential factor for the survival after radiotherapy for brain metastases from the pulmonary tumor in the 45 patients. China Oncology 2006, 16:310-312.
18. Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005, 63:324-333. 10.1016/j.ijrobp.2005.02.010, 16168827.